36924-81-9

Basic information

• Product Name: ethyl 2-(4-aminophenyl)-2-methylpropanoate
• Synonyms: ethyl 2-(4-aminophenyl)-2-methylpropanoate
• CAS NO: 36924-81-9
• Molecular Weight: 207.272
• Mol File: 36924-81-9.mol
• Article Data: 29

Chemical Properties

• CAS DataBase Reference: ethyl 2-(4-aminophenyl)-2-methylpropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-(4-aminophenyl)-2-methylpropanoate(36924-81-9)
• EPA Substance Registry System: ethyl 2-(4-aminophenyl)-2-methylpropanoate(36924-81-9)

Safety Data

• Hazardous Substances Data: 36924-81-9(Hazardous Substances Data)

Upstream product

• 83397-45-9 ethyl 2-methyl-2-(4-nitrophenyl)propanoate 
• 1195-98-8 2-methyl-2-phenylpropionitrile 
• 5445-26-1 ETHYL 4-NITROPHENYLACETATE 
• 71825-51-9 4-(2-cyanoprop-2-yl)-1-nitrobenzene 
• 98-95-3 nitrobenzene 

Downstream Products

• 357193-01-2 ethyl 2-(4-amino-3-iodophenyl)-2-methylpropanoate 
• 1009083-03-7 2-[4-(3-{2-[2-(2-chloro-phenyl)-5-methyl-2H-pyrazol-3-yloxy]-phenyl}-ureido)-phenyl]-2-methyl-propionic acid ethyl ester 
• 18755-56-1 2-(4-aminophenyl)-2-methylpropan-1-ol 
• 1076219-29-8 2-[2-(3,5-dimethylphenyl)-1H-indol-5-yl]-(N-cyclopropyl)-2-methylpropanamide 
• 1076220-87-5 2-[2-(3,5-dimethylphenyl)-1H-indol-5-yl]-2-methylpropanoic acid 
• 1076219-12-9 ethyl 2-methyl-2-{2-[4-(trifluoromethoxy)phenyl]-1H-indol-5-yl}propanoate 
• 1076219-11-8 ethyl 2-[2-(3,5-dimethylphenyl)-1H-indol-5-yl]-2-methylpropanoate 
• 192643-90-6 ethyl 2-(4-hydrazinophenyl)-2-methylpropanoate 
• 81265-70-5 2-(4-Indazol-2-yl-phenyl)-2-methyl-propionic acid 
• 193017-14-0 [2-[5-(1,1-dimethyl-2-oxo-2-pyrrolidin-1-ylethyl)-2-(3,5-dimethylphenyl)-1H-indol-3-yl]ethyl]-[4-(4-methane-sulfonylaminophenyl)butyl]carbamic Acid Benzyl Ester 
• 192774-13-3 {2-[5-(1-diethylcarbamoyl-1-methylethyl)-2-(3,5-dimethylphenyl)-1H-indol-3-yl]ethyl}-[4-(4-methanesulfonylaminophenyl)butyl]carbamic acid benzyl ester 

Relevant articles and documents

COMPOUNDS AND METHODS FOR INHIBITING CYP26 ENZYMES

Compounds described herein are inhibitors of retinoic acid inducible P450 (CYP26) enzymes, and are useful for treating diseases that are responsive to retinoids. Certain compounds have retinoid activity, are resistant to CYP26-mediated catabolism, and are used for treating diseases that are responsive to retinoids.

2,4-Pyrimidinediamine Compounds and Their Uses

The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.